Gil Blum
Stock Analyst at Needham
(4.77)
# 578
Out of 4,685 analysts
724
Total ratings
47.9%
Success rate
16.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $56 | $33.74 | +65.98% | 1 | Aug 21, 2026 | |
| CELC Celcuity | Rated: Buy | $157 → $140 | $93.24 | +50.15% | 34 | Aug 14, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | n/a | $2.54 | - | 24 | Aug 13, 2026 | |
| TSHA Taysha Gene Therapies | Maintained: Buy | $12 | $5.96 | +101.34% | 50 | Aug 12, 2026 | |
| TCRX TScan Therapeutics | Maintained: Buy | $6 | $0.7502 | +699.79% | 18 | Aug 12, 2026 | |
| ABSI Absci | Maintained: Buy | $11 | $9.42 | +16.77% | 14 | Aug 12, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | n/a | $3.62 | - | 50 | Aug 11, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Buy | $3 | $0.272 | +1,002.94% | 35 | Aug 11, 2026 | |
| AUTL Autolus Therapeutics | Reiterated: Buy | $10 | $2.36 | +323.73% | 52 | Aug 11, 2026 | |
| NKTX Nkarta | Maintained: Buy | $11 | $2.75 | +300.00% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $14.31 | +46.75% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $10.13 | +87.56% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $14.61 | +201.16% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $11.94 | +243.38% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $21.59 | - | 56 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $9.97 | +301.20% | 37 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $36.75 | +104.08% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.53 | +161.44% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.44 | +132.56% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 | $59.37 | +38.12% | 42 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $26.88 | +26.51% | 48 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.65 | - | 28 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.89 | - | 25 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.04 | n/a | 15 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 400.00 → kr 371.00 | kr 213.60 | n/a | 16 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $36.70 | n/a | 14 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $93.62 | n/a | 10 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 5 | Apr 6, 2022 |
Faeth Therapeutics
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $56
Current: $33.74
Upside: +65.98%
Celcuity
Aug 14, 2026
Rated: Buy
Price Target: $157 → $140
Current: $93.24
Upside: +50.15%
Fate Therapeutics
Aug 13, 2026
Maintained: Hold
Price Target: n/a
Current: $2.54
Upside: -
Taysha Gene Therapies
Aug 12, 2026
Maintained: Buy
Price Target: $12
Current: $5.96
Upside: +101.34%
TScan Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $6
Current: $0.7502
Upside: +699.79%
Absci
Aug 12, 2026
Maintained: Buy
Price Target: $11
Current: $9.42
Upside: +16.77%
Rocket Pharmaceuticals
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $3.62
Upside: -
Mereo BioPharma Group
Aug 11, 2026
Maintained: Buy
Price Target: $3
Current: $0.272
Upside: +1,002.94%
Autolus Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $10
Current: $2.36
Upside: +323.73%
Nkarta
Aug 11, 2026
Maintained: Buy
Price Target: $11
Current: $2.75
Upside: +300.00%
Aug 10, 2026
Maintained: Buy
Price Target: $21
Current: $14.31
Upside: +46.75%
Aug 7, 2026
Maintained: Buy
Price Target: $19
Current: $10.13
Upside: +87.56%
Aug 7, 2026
Maintained: Buy
Price Target: $44
Current: $14.61
Upside: +201.16%
Aug 7, 2026
Maintained: Buy
Price Target: $41
Current: $11.94
Upside: +243.38%
Aug 6, 2026
Reiterated: Sell
Price Target: n/a
Current: $21.59
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: $40
Current: $9.97
Upside: +301.20%
Aug 6, 2026
Maintained: Buy
Price Target: $75
Current: $36.75
Upside: +104.08%
Aug 5, 2026
Maintained: Buy
Price Target: $4
Current: $1.53
Upside: +161.44%
Aug 5, 2026
Maintained: Buy
Price Target: $8
Current: $3.44
Upside: +132.56%
Aug 4, 2026
Maintained: Buy
Price Target: $82
Current: $59.37
Upside: +38.12%
Aug 4, 2026
Maintained: Buy
Price Target: $34
Current: $26.88
Upside: +26.51%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $7.65
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.89
Upside: -
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $6.04
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: kr 400.00 → kr 371.00
Current: kr 213.60
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $6
Current: $36.70
Upside: n/a
Aug 25, 2022
Rated: Hold
Price Target: n/a
Current: $93.62
Upside: n/a
Jun 3, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 6, 2022
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a